Cathie Wood Entera Bio Ltd. Transaction History

Ark Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$1.33 - $2.95 $2,319 - $5,144	-1,744 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$1.91 - $3.23 $1.32 Million - $2.23 Million	-689,178 Reduced 99.75%	1,744 $5,000
Q4 2021 Jan 28, 2022	BUY	$2.82 - $4.79 $22,320 - $37,912	7,915 Added 1.16%	690,922 $1.95 Million
Q3 2021 Nov 12, 2021	BUY	$4.43 - $6.29 $3.03 Million - $4.3 Million	683,007 New	683,007 $3.22 Million

5.34M

2.6K

100

Ticker ENTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,809,900
Market Cap $65.1M
Description
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.